This page is part of the FHIR Specification (v1.8.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3 R2
The manufacturer of a vaccine.
<ValueSet xmlns="http://hl7.org/fhir"> <id value="v3-VaccineManufacturer"/> <meta> <lastUpdated value="2016-11-11T00:00:00.000+11:00"/> <profile value="http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"/> </meta> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p>Release Date: 2016-11-11</p> <table class="grid"> <tr> <td> <b>Level</b> </td> <td> <b>Code</b> </td> <td> <b>Display</b> </td> <td> <b>Definition</b> </td> </tr> <tr> <td>1</td> <td>AB <a name="AB"> </a> </td> <td>Abbott Laboratories (includes Ross Products Division)</td> <td> Abbott Laboratories (includes Ross Products Division) <br/> </td> </tr> <tr> <td>1</td> <td>AD <a name="AD"> </a> </td> <td>Adams Laboratories</td> <td> Adams Laboratories <br/> </td> </tr> <tr> <td>1</td> <td>ALP <a name="ALP"> </a> </td> <td>Alpha Therapeutic Corporation</td> <td> Alpha Therapeutic Corporation <br/> </td> </tr> <tr> <td>1</td> <td>AR <a name="AR"> </a> </td> <td>Armour [Inactive - use CEN]</td> <td> Armour [Inactive-use CEN] <br/> </td> </tr> <tr> <td>1</td> <td>AVI <a name="AVI"> </a> </td> <td>Aviron</td> <td> Aviron <br/> </td> </tr> <tr> <td>1</td> <td>BA <a name="BA"> </a> </td> <td>Baxter Healthcare Corporation</td> <td> Baxter Healthcare Corporation <br/> </td> </tr> <tr> <td>1</td> <td>BAY <a name="BAY"> </a> </td> <td>Bayer Corporation (includes Miles, Inc. and Cutter Laboratories)</td> <td> Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) <br/> </td> </tr> <tr> <td>1</td> <td>BP <a name="BP"> </a> </td> <td>Berna Products [Inactive - use BPC]</td> <td> Berna Products [Inactive-use BPC] <br/> </td> </tr> <tr> <td>1</td> <td>BPC <a name="BPC"> </a> </td> <td>Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne)</td> <td> Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne) <br/> </td> </tr> <tr> <td>1</td> <td>CEN <a name="CEN"> </a> </td> <td>Centeon L.L.C. (includes Armour Pharmaceutical Company)</td> <td> Centeon L.L.C. (includes Armour Pharmaceutical Company) <br/> </td> </tr> <tr> <td>1</td> <td>CHI <a name="CHI"> </a> </td> <td>Chiron Corporation</td> <td> Chiron Corporation <br/> </td> </tr> <tr> <td>1</td> <td>CON <a name="CON"> </a> </td> <td>Connaught [Inactive - use PMC]</td> <td> Connaught [Inactive-use PMC] <br/> </td> </tr> <tr> <td>1</td> <td>EVN <a name="EVN"> </a> </td> <td>Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.)</td> <td> Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.) <br/> </td> </tr> <tr> <td>1</td> <td>GRE <a name="GRE"> </a> </td> <td>Greer Laboratories, Inc.</td> <td> Greer Laboratories, Inc. <br/> </td> </tr> <tr> <td>1</td> <td>IAG <a name="IAG"> </a> </td> <td>Immuno International AG</td> <td> Immuno International AG <br/> </td> </tr> <tr> <td>1</td> <td>IM <a name="IM"> </a> </td> <td>Merieux [Inactive - use PMC]</td> <td> Merieux [Inactive-use PMC] <br/> </td> </tr> <tr> <td>1</td> <td>IUS <a name="IUS"> </a> </td> <td>Immuno-U.S., Inc.</td> <td> Immuno-U.S., Inc. <br/> </td> </tr> <tr> <td>1</td> <td>JPN <a name="JPN"> </a> </td> <td>The Research Foundation for Microbial Diseases of Osaka University (BIKEN)</td> <td> The Research Foundation for Microbial Diseases of Osaka University (BIKEN) <br/> </td> </tr> <tr> <td>1</td> <td>KGC <a name="KGC"> </a> </td> <td>Korea Green Cross Corporation</td> <td> Korea Green Cross Corporation <br/> </td> </tr> <tr> <td>1</td> <td>LED <a name="LED"> </a> </td> <td>Lederle [Inactive - use WAL]</td> <td> Lederle [Inactive-use WAL] <br/> </td> </tr> <tr> <td>1</td> <td>MA <a name="MA"> </a> </td> <td>Massachusetts Public Health Biologic Laboratories</td> <td> Massachusetts Public Health Biologic Laboratories <br/> </td> </tr> <tr> <td>1</td> <td>MED <a name="MED"> </a> </td> <td>MedImmune, Inc.</td> <td> MedImmune, Inc. <br/> </td> </tr> <tr> <td>1</td> <td>MIL <a name="MIL"> </a> </td> <td>Miles [Inactive - use BAY]</td> <td> Miles [Inactive-use BAY] <br/> </td> </tr> <tr> <td>1</td> <td>MIP <a name="MIP"> </a> </td> <td>Bioport Corporation (formerly Michigan Biologic Products Institute)</td> <td> Bioport Corporation (formerly Michigan Biologic Products Institute) <br/> </td> </tr> <tr> <td>1</td> <td>MSD <a name="MSD"> </a> </td> <td>Merck and Co., Inc.</td> <td> Merck & Co., Inc. <br/> </td> </tr> <tr> <td>1</td> <td>NAB <a name="NAB"> </a> </td> <td>NABI (formerly North American Biologicals, Inc.)</td> <td> NABI (formerly North American Biologicals, Inc.) <br/> </td> </tr> <tr> <td>1</td> <td>NAV <a name="NAV"> </a> </td> <td>North American Vaccine, Inc.</td> <td> North American Vaccine, Inc. <br/> </td> </tr> <tr> <td>1</td> <td>NOV <a name="NOV"> </a> </td> <td>Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited)</td> <td> Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited) <br/> </td> </tr> <tr> <td>1</td> <td>NYB <a name="NYB"> </a> </td> <td>New York Blood Center</td> <td> New York Blood Center <br/> </td> </tr> <tr> <td>1</td> <td>ORT <a name="ORT"> </a> </td> <td>Ortho Diagnostic Systems, Inc.</td> <td> Ortho Diagnostic Systems, Inc. <br/> </td> </tr> <tr> <td>1</td> <td>OTC <a name="OTC"> </a> </td> <td>Organon Teknika Corporation</td> <td> Organon Teknika Corporation <br/> </td> </tr> <tr> <td>1</td> <td>PD <a name="PD"> </a> </td> <td>Parkedale Pharmaceuticals (formerly Parke-Davis)</td> <td> Parkedale Pharmaceuticals (formerly Parke-Davis) <br/> </td> </tr> <tr> <td>1</td> <td>PMC <a name="PMC"> </a> </td> <td>Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux)</td> <td> Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) <br/> </td> </tr> <tr> <td>1</td> <td>PRX <a name="PRX"> </a> </td> <td>Praxis Biologics [Inactive - use WAL]</td> <td> Praxis Biologics [Inactive-use WAL] <br/> </td> </tr> <tr> <td>1</td> <td>SCL <a name="SCL"> </a> </td> <td>Sclavo, Inc.</td> <td> Sclavo, Inc. <br/> </td> </tr> <tr> <td>1</td> <td>SI <a name="SI"> </a> </td> <td>Swiss Serum and Vaccine Inst. [Inactive - use BPC]</td> <td> Swiss Serum and Vaccine Inst. [Inactive-use BPC] <br/> </td> </tr> <tr> <td>1</td> <td>SKB <a name="SKB"> </a> </td> <td>SmithKline Beecham</td> <td> SmithKline Beecham <br/> </td> </tr> <tr> <td>1</td> <td>USA <a name="USA"> </a> </td> <td>United States Army Medical Research and Materiel Command</td> <td> United States Army Medical Research and Materiel Command <br/> </td> </tr> <tr> <td>1</td> <td>WA <a name="WA"> </a> </td> <td>Wyeth-Ayerst [Inactive - use WAL]</td> <td> Wyeth-Ayerst [Inactive-use WAL] <br/> </td> </tr> <tr> <td>1</td> <td>WAL <a name="WAL"> </a> </td> <td>Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)</td> <td> Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) <br/> </td> </tr> </table> </div> </text> <url value="http://hl7.org/fhir/ValueSet/v3-VaccineManufacturer"/> <identifier> <system value="urn:ietf:rfc:3986"/> <value value="urn:oid:2.16.840.1.113883.1.11.227"/> </identifier> <version value="2016-11-11"/> <name value="v3 Code System VaccineManufacturer"/> <status value="active"/> <experimental value="false"/> <publisher value="HL7, Inc"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org"/> </telecom> </contact> <date value="2016-11-11"/> <description value=" The manufacturer of a vaccine."/> <immutable value="true"/> <compose> <include> <system value="http://hl7.org/fhir/v3/VaccineManufacturer"/> </include> </compose> </ValueSet>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.